Pernod Ricard (RI) Investor Update summary
Event summary combining transcript, slides, and related documents.
Investor Update summary
18 Nov, 2025Revenue growth management and pricing strategy
Significant reset of pricing strategies over the past year, focusing on competitive positioning and agility in response to market dynamics.
Enhanced revenue growth management capabilities with dedicated teams, advanced tools, and data-driven processes for sharper decision-making.
Strategic focus on promotional intensity, ensuring spend is phased and targeted for key brands.
Rev-Up RGM system now covers the full portfolio, providing detailed, data-driven insights.
Portfolio prioritization and wholesaler realignment
Comprehensive review and realignment of wholesaler partnerships, prioritizing performance and resource allocation by state.
Mainline and explode brands now account for 80% of net sales, with clear focus and resource dedication.
Enhanced clarity on KPIs and commercial requirements, fostering stronger collaboration and engagement with wholesalers.
Final stages of new wholesaler contracts, with positive feedback on portfolio prioritization and support.
Brand momentum and innovation
Volume and value gaps to market have narrowed significantly, indicating positive momentum.
Strong plans and innovation initiatives, including new sponsorships (e.g., Jameson as MLS whiskey sponsor) and targeted brand activations.
Jameson recovery driven by increased investment in awareness, advocacy, and portfolio clarity, with household penetration still offering growth headroom.
RTDs leveraged for recruitment, with partnerships like Absolut and Ocean Spray expanding reach.
Latest events from Pernod Ricard
- Sales and profit fell, but free cash flow improved and medium-term growth targets reaffirmed.RI
H1 202619 Feb 2026 - Q1 organic sales fell 7.6%, but H2 is expected to improve as key markets recover.RI
Q1 20263 Feb 2026 - Organic sales down 1%, margins up, net profit down 35%, FY25 growth expected.RI
H2 202423 Jan 2026 - Q1 sales declined 5.9% organically, with China and US driving the downturn; guidance unchanged.RI
Q1 202519 Jan 2026 - Stable sales, margin gains, and a €4.70 dividend headline a governance-focused AGM.RI
AGM 202415 Jan 2026 - Margin and cash flow improved despite sales and profit declines amid FX and China headwinds.RI
H1 20259 Jan 2026 - Resilient results, stable dividends, and all resolutions approved amid global challenges.RI
AGM 202527 Dec 2025 - Q3 FY25 organic net sales fell 3%, but FY25 outlook and €2.35 dividend were confirmed.RI
Q3 202521 Dec 2025 - Organic sales fell 3% but margin and cash flow improved; FY26 to be a transition year.RI
H2 202523 Nov 2025